Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cardiac-specific loss of mitoNEET expression is linked with age-related heart failure.
Furihata T, Takada S, Kakutani N, Maekawa S, Tsuda M, Matsumoto J, Mizushima W, Fukushima A, Yokota T, Enzan N, Matsushima S, Handa H, Fumoto Y, Nio-Kobayashi J, Iwanaga T, Tanaka S, Tsutsui H, Sabe H, Kinugawa S. Furihata T, et al. Among authors: matsumoto j. Commun Biol. 2021 Jan 29;4(1):138. doi: 10.1038/s42003-021-01675-4. Commun Biol. 2021. PMID: 33514783 Free PMC article.
Direct renin inhibitor ameliorates insulin resistance by improving insulin signaling and oxidative stress in the skeletal muscle from post-infarct heart failure in mice.
Fukushima A, Kinugawa S, Takada S, Matsumoto J, Furihata T, Mizushima W, Tsuda M, Yokota T, Matsushima S, Okita K, Tsutsui H. Fukushima A, et al. Among authors: matsumoto j. Eur J Pharmacol. 2016 May 15;779:147-56. doi: 10.1016/j.ejphar.2016.03.022. Epub 2016 Mar 14. Eur J Pharmacol. 2016. PMID: 26988296 Free article.
Dipeptidyl peptidase-4 inhibitor improved exercise capacity and mitochondrial biogenesis in mice with heart failure via activation of glucagon-like peptide-1 receptor signalling.
Takada S, Masaki Y, Kinugawa S, Matsumoto J, Furihata T, Mizushima W, Kadoguchi T, Fukushima A, Homma T, Takahashi M, Harashima S, Matsushima S, Yokota T, Tanaka S, Okita K, Tsutsui H. Takada S, et al. Among authors: matsumoto j. Cardiovasc Res. 2016 Sep;111(4):338-47. doi: 10.1093/cvr/cvw182. Epub 2016 Jul 21. Cardiovasc Res. 2016. PMID: 27450980
The novel heart-specific RING finger protein 207 is involved in energy metabolism in cardiomyocytes.
Mizushima W, Takahashi H, Watanabe M, Kinugawa S, Matsushima S, Takada S, Yokota T, Furihata T, Matsumoto J, Tsuda M, Chiba I, Nagashima S, Yanagi S, Matsumoto M, Nakayama KI, Tsutsui H, Hatakeyama S. Mizushima W, et al. Among authors: matsumoto j, matsumoto m. J Mol Cell Cardiol. 2016 Nov;100:43-53. doi: 10.1016/j.yjmcc.2016.09.013. Epub 2016 Sep 25. J Mol Cell Cardiol. 2016. PMID: 27677939 Free article.
The experimental model of transition from compensated cardiac hypertrophy to failure created by transverse aortic constriction in mice.
Furihata T, Kinugawa S, Takada S, Fukushima A, Takahashi M, Homma T, Masaki Y, Tsuda M, Matsumoto J, Mizushima W, Matsushima S, Yokota T, Tsutsui H. Furihata T, et al. Among authors: matsumoto j. Int J Cardiol Heart Vasc. 2016 Mar 16;11:24-28. doi: 10.1016/j.ijcha.2016.03.007. eCollection 2016 Jun. Int J Cardiol Heart Vasc. 2016. PMID: 28616522 Free PMC article.
Protein acetylation in skeletal muscle mitochondria is involved in impaired fatty acid oxidation and exercise intolerance in heart failure.
Tsuda M, Fukushima A, Matsumoto J, Takada S, Kakutani N, Nambu H, Yamanashi K, Furihata T, Yokota T, Okita K, Kinugawa S, Anzai T. Tsuda M, et al. Among authors: matsumoto j. J Cachexia Sarcopenia Muscle. 2018 Oct;9(5):844-859. doi: 10.1002/jcsm.12322. Epub 2018 Aug 30. J Cachexia Sarcopenia Muscle. 2018. PMID: 30168279 Free PMC article.
Brain-Derived Neurotrophic Factor Improves Limited Exercise Capacity in Mice With Heart Failure.
Matsumoto J, Takada S, Kinugawa S, Furihata T, Nambu H, Kakutani N, Tsuda M, Fukushima A, Yokota T, Tanaka S, Takahashi H, Watanabe M, Hatakeyama S, Matsumoto M, Nakayama KI, Otsuka Y, Sabe H, Tsutsui H, Anzai T. Matsumoto J, et al. Among authors: matsumoto m. Circulation. 2018 Oct 30;138(18):2064-2066. doi: 10.1161/CIRCULATIONAHA.118.035212. Circulation. 2018. PMID: 30372141 No abstract available.
Empagliflozin restores lowered exercise endurance capacity via the activation of skeletal muscle fatty acid oxidation in a murine model of heart failure.
Nambu H, Takada S, Fukushima A, Matsumoto J, Kakutani N, Maekawa S, Shirakawa R, Nakano I, Furihata T, Katayama T, Yamanashi K, Obata Y, Saito A, Yokota T, Kinugawa S. Nambu H, et al. Among authors: matsumoto j. Eur J Pharmacol. 2020 Jan 5;866:172810. doi: 10.1016/j.ejphar.2019.172810. Epub 2019 Nov 15. Eur J Pharmacol. 2020. PMID: 31738936 Free article.
Inhibition of xanthine oxidase in the acute phase of myocardial infarction prevents skeletal muscle abnormalities and exercise intolerance.
Nambu H, Takada S, Maekawa S, Matsumoto J, Kakutani N, Furihata T, Shirakawa R, Katayama T, Nakajima T, Yamanashi K, Obata Y, Nakano I, Tsuda M, Saito A, Fukushima A, Yokota T, Nio-Kobayashi J, Yasui H, Higashikawa K, Kuge Y, Anzai T, Sabe H, Kinugawa S. Nambu H, et al. Among authors: matsumoto j. Cardiovasc Res. 2021 Feb 22;117(3):805-819. doi: 10.1093/cvr/cvaa127. Cardiovasc Res. 2021. PMID: 32402072
1,169 results